Anti-NOX2/gp91phox [54.1] Antibody
![Anti-NOX2/gp91phox [54.1] Antibody](https://www.kerafast.com/MediaStorage/Product/Images/Large/844_200120200126248430.jpg "Anti-NOX2/gp91phox [54.1] Antibody")
This IgG1 mouse mononoclonal antibody was generated against the partially purified human neutrophil flavocytochrome b (cytochrome b559 or cytochrome b558) and is reactive against human gp91phox amino acids 382-389.
Gp91phox (portion of the heterodimer Cytochrome b) is a critical component of the membrane-bound oxidase of phagocytes that generates superoxide. It is the terminal component of a respiratory chain that transfers single electrons from cytoplasmic NADPH across the plasma membrane to molecular oxygen on the exterior. It also functions as a voltage-gated proton channel that mediates the H(+) currents of resting phagocytes. Defects in the CYBB gene are a cause of X-linked chronic granulomatous disease (X-CGD). X-CGD is characterized by the failure of activated phagocytes to generate superoxide and patients suffer from life-threatening bacterial/fungal infections.
From the laboratory of Algirdas J. Jesaitis, PhD, Montana State University.
Part of The Investigator's Annexe program.
This IgG1 mouse mononoclonal antibody was generated against the partially purified human neutrophil flavocytochrome b (cytochrome b559 or cytochrome b558) and is reactive against human gp91phox amino acids 382-389.
Gp91phox (portion of the heterodimer Cytochrome b) is a critical component of the membrane-bound oxidase of phagocytes that generates superoxide. It is the terminal component of a respiratory chain that transfers single electrons from cytoplasmic NADPH across the plasma membrane to molecular oxygen on the exterior. It also functions as a voltage-gated proton channel that mediates the H(+) currents of resting phagocytes. Defects in the CYBB gene are a cause of X-linked chronic granulomatous disease (X-CGD). X-CGD is characterized by the failure of activated phagocytes to generate superoxide and patients suffer from life-threatening bacterial/fungal infections.
From the laboratory of Algirdas J. Jesaitis, PhD, Montana State University.
Part of The Investigator's Annexe program.
| Product Type: | Antibody |
| Name: | Anti-NOX2/gp91phox [54.1] Antibody (Alternative names: AMCBX2 antibody, CGD antibody, CGD91-phox antibody, CY24B_HUMAN antibody, CYBB antibody) |
| Accession ID: | P04839 |
| Molecular Weight: | 65 kDa |
| Isotype: | IgG1 |
| Clonality: | Monoclonal |
| Clone Name: | 54.1 |
| Reactivity: | Human |
| Specificity: | Human gp91phox 382-PKIAVDGP-389 |
| Immunogen: | Partially purified human neutrophil flavocytochrome b (heparin Ultrogel/lectin affinity purification ? in Triton X-100) |
| Species Immunized: | Mouse |
| Myeloma Used: | SP2/0 |
| Purification Method: | Protein G |
| Buffer: | 0.1M Sodium Phosphate, pH 7.4, 0.15M NaCl, 0.05% (w/v) Sodium Azide |
| Tested Applications: | WB (1:1000) |
| Storage: | -20C |
| Shipped: | Cold packs |
Specificity of mAb for cytochrome b and phage pIII proteins. Intact phage expressing known amino acid sequences (lanes B, C, E, and F) and partially purified cytochrome b (lanes A and D) were separated on SDS-PAGE polyacrylamide gels and transferred to nitrocellulose. Samples were Western blotted with mAb 54.1 (lanes A-C) or mAb 44.1 (lanes D-F). Lanes B and F contain proteins of phage sequence 3 (PQVRPI), and lanes C and E contain proteins of phage sequence 27 (FKRGVD.
Adapted from: Burritt, J.B. et al. J.Biol.Chem. 270:16974-16980, 1995.
- Burritt, J.B., Quinn, M.T., Jutila, M.A., Bond, C.W. and Jesaitis, A.J. Topological mapping of neutrophil cytochrome b epitopes with phage display libraries. J.Biol.Chem. 270:16974-16980, 1995.
- Danas B., Yoko N., William M. Nauseef, Botond Banfi Guangjie Cheng, David J. Lambeth, James B. Burritt, Ross M. Taylor, Algirdas J. Jesaitis. Evaluation of two anti-gp91phox antibodies as immunoprobes for Nox family proteins: mAb 54.1 recognizes recombinant full-length Nox2, Nox3 and the C-terminal domains of Nox1-4 and cross-reacts with GRP 58. Biochimica et Biophysica Acta 1752 (2005) 186 196.
If you publish research with this product, please let us know so we can cite your paper.
